Reviewer Board
Members of the reviewer board are selected from all Cancers reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
1. Gustave Roussy, Plate-Forme Imagerie et Cytométrie, UMS 23/3655, Université Paris-Saclay, Villejuif, France
2. Université Paris-Saclay, CEA, CNRS, Inserm, Laboratoire d'Imagerie Biomédicale Multimodale, Orsay, France
Interests: cancer; fluorescence; near infrared imaging; indocyanine green; endomicroscopy; optical coherence tomography
2. Université Paris-Saclay, CEA, CNRS, Inserm, Laboratoire d'Imagerie Biomédicale Multimodale, Orsay, France
Interests: cancer; fluorescence; near infrared imaging; indocyanine green; endomicroscopy; optical coherence tomography
Laboratory of catecholamines and peptides, Service of clinical pharmacology, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
Interests: metabolism of catecholamine in adrenal medulla and pheochromocytoma; measurement of catecholamine and metabolites for diagnosis of neuroendocrine tumors; optimization of radionucleide (MIBG and somatostatine analogues) uptake and binding in cancer cells
Interests: metabolism of catecholamine in adrenal medulla and pheochromocytoma; measurement of catecholamine and metabolites for diagnosis of neuroendocrine tumors; optimization of radionucleide (MIBG and somatostatine analogues) uptake and binding in cancer cells
Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
Interests: cancer metabolism; metabolic flux analysis; systems biology; bioinformatics; Machine learning; precision medicine; personalized medicine
Interests: cancer metabolism; metabolic flux analysis; systems biology; bioinformatics; Machine learning; precision medicine; personalized medicine
Department of Neurosurgery and Cyberknife center, Charité Universitätsmedizin Berlin, Berlin, Germany
Interests: glioblastoma multiforme; angiogenesis; radiosurgery; radionecrosis; PET; moyamoya; 3D imaging; radiation biology
Interests: glioblastoma multiforme; angiogenesis; radiosurgery; radionecrosis; PET; moyamoya; 3D imaging; radiation biology
Department of Oncology, University Hospital of Geneva, 1205 Genève, Switzerland
Interests: NSCLC; sclc; biomarkers; tumour mutations burden; oncogene driver mutations; immunotherapy
Interests: NSCLC; sclc; biomarkers; tumour mutations burden; oncogene driver mutations; immunotherapy
1. Department of Oncology, Georgetown University School of Medicine, Washington, DC, USA
2. Terasaki Institute of Biomedical Innovation, Los Angeles, CA, USA
Interests: cancer epidemiology; Cancer prevention; survivorship; health outcomes research
2. Terasaki Institute of Biomedical Innovation, Los Angeles, CA, USA
Interests: cancer epidemiology; Cancer prevention; survivorship; health outcomes research
Stem Cell Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy
Interests: mesenchymal stem cells; cancer; drug delivery; good manufacturing practice; cell therapy; medium additive substitutes; microfluidic conditions
Interests: mesenchymal stem cells; cancer; drug delivery; good manufacturing practice; cell therapy; medium additive substitutes; microfluidic conditions
School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, and Curtin Institute for Computation, Curtin University, Perth, WA 6102, Australia
Interests: computer-aided drug design; lead optimization; molecular recognition; structural biology; molecular docking; virtual screening; molecular dynamics; binding free energy calculations; wnt signalling; glycobiology
Interests: computer-aided drug design; lead optimization; molecular recognition; structural biology; molecular docking; virtual screening; molecular dynamics; binding free energy calculations; wnt signalling; glycobiology
Molecular Imaging Program, National Cancer Institute/National Institutes of Health, Bethesda, MD 20892, USA
Interests: cancer; glioblastoma; prostate cancer; anticancer agents; metabolomics; hyperpolarized metabolic & AMP; molecular imaging; radio carbon tracing; biomarker discovery; primary & 3D cell culture
Interests: cancer; glioblastoma; prostate cancer; anticancer agents; metabolomics; hyperpolarized metabolic & AMP; molecular imaging; radio carbon tracing; biomarker discovery; primary & 3D cell culture
Dr. Atif Ali Ahmed
University of Washington, Seattle, USA
Seattle Children's Hospital
4800 Sand Point Way NE, Seattle, WA 98105
USA
Interests: rhabdomyosarcoma; neuroblastoma; ewing's sarcoma
Interests: rhabdomyosarcoma; neuroblastoma; ewing's sarcoma
School of Medicine, Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland SR1 3SD, UK
Interests: glioblastoma; cell cycle; cell death; DNA damage; hypoxia
Interests: glioblastoma; cell cycle; cell death; DNA damage; hypoxia
Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, QC H3A 0G4, Canada
Interests: cancer; cell signaling; Protein Kinase; RTK; migration; invasion; drug discovery
Interests: cancer; cell signaling; Protein Kinase; RTK; migration; invasion; drug discovery
School of Pharmacy, The University of Texas at El Paso, TX 79902, USA
Interests: cancer angiogenesis; growth factor signaling; cancer fibrosis; cancer thrombosis; bioengineering cancer models; mirofluidics and cancer
Interests: cancer angiogenesis; growth factor signaling; cancer fibrosis; cancer thrombosis; bioengineering cancer models; mirofluidics and cancer
Department of Clinical Sciences and Translational Medicine, School of Medicine, University of Rome, “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy
Interests: analysis of molecular mechanisms associated with tumor growth and progression related to angiogenesis; analysis of molecular mechanisms associated with polarized immune cells in tumor microenvironment
Interests: analysis of molecular mechanisms associated with tumor growth and progression related to angiogenesis; analysis of molecular mechanisms associated with polarized immune cells in tumor microenvironment
Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, 84081 Baronissi (SA), Italy
Interests: breast cancer; ovarian cancer; endocrine resistance; anti-cancer drugs; targeted therapy; Estrogen Receptor Modulators; cancer genomics; epigenetics
Interests: breast cancer; ovarian cancer; endocrine resistance; anti-cancer drugs; targeted therapy; Estrogen Receptor Modulators; cancer genomics; epigenetics
Department of Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, OR 97201, USA
Interests: pancreatic cancer; phosphatases; cancer cell signaling; cellular plasticity; PP2A, therapeutic response; 3D culture; mouse models of cancer
Interests: pancreatic cancer; phosphatases; cancer cell signaling; cellular plasticity; PP2A, therapeutic response; 3D culture; mouse models of cancer
Unit of Nuclear Medicine, Fondazione Istituto G. Giglio, 90015 Cefalù, Italy
Interests: PET/CT; SPECT; prostate cancer; molecular imaging; Neuroimaging
Interests: PET/CT; SPECT; prostate cancer; molecular imaging; Neuroimaging
Institut d'Investigació Germans Trias i Pujol (IGTP), Campus Can Ruti, 08916 Badalona, Spain
Interests: cancer epigenetics; Cancer Genetics; colorectal cancer; DNA methylation; epigenomics; gastrointestinal cancer; genomics; bioinformatics and computational biology
Interests: cancer epigenetics; Cancer Genetics; colorectal cancer; DNA methylation; epigenomics; gastrointestinal cancer; genomics; bioinformatics and computational biology
Bone Physiophatology Laboratory, Department of Basic Medical Sciences,
San Pablo CEU University, CEU Universities, Campus Monteprincipe, 28925 Alcorcón, Spain
Interests: bone metastases; mindin; prostate cancer; pre metastatic niche; pth1r; bone signaling
Interests: bone metastases; mindin; prostate cancer; pre metastatic niche; pth1r; bone signaling
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
Interests: cancer biology; gene regulation; myc; epigenetics; chromatin modifiers; polycomb; epigenetic therapy
Interests: cancer biology; gene regulation; myc; epigenetics; chromatin modifiers; polycomb; epigenetic therapy
UCIBIO.REQUIMTE, Laboratory of Biochemistry, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
Interests: breast cancer; endocrine/acquired resistance; anti-cancer drugs; targeted therapy; aromatase inhibitors; estrogen receptor modulators; cannabinoids; apoptosis; autophagy; cell cycle; cell signalling pathways
Interests: breast cancer; endocrine/acquired resistance; anti-cancer drugs; targeted therapy; aromatase inhibitors; estrogen receptor modulators; cannabinoids; apoptosis; autophagy; cell cycle; cell signalling pathways
Department of Health Science, Digestive Surgery Unit, Magna Graecia University, Catanzaro, Italy
Interests: oncological surgery; gastrointestinal surgery; tumor angiogenesis; tumor microenviroment
Interests: oncological surgery; gastrointestinal surgery; tumor angiogenesis; tumor microenviroment
Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, 00167 Roma, Italy
Interests: cervical cancer; Endometrial Cancer; ovarian cancer; fertility sparing; oncological surgery; minimally invasive; laparoscopy; robotic surgery
Interests: cervical cancer; Endometrial Cancer; ovarian cancer; fertility sparing; oncological surgery; minimally invasive; laparoscopy; robotic surgery
Department of Pathology, University of Gothenburg, 405 30 Gothenburg, Sweden
Interests: MYB; cancer genomics; salivary gland tumors; cylindroma; pediatric acute leukemia
Interests: MYB; cancer genomics; salivary gland tumors; cylindroma; pediatric acute leukemia
Department of Clinical and Experimental Biomedical Sciences "Mario Serio", Section of Experimental Pathology and Oncology, University of Florence, Viale Morgagni 50, 50134 Florence, Italy
Interests: tumor microenvironment; extracellular acidosis; tumor angiogenesis; tumor-derived extracellular vescicles (exososmes-ectososmes); cancer metabolism
Interests: tumor microenvironment; extracellular acidosis; tumor angiogenesis; tumor-derived extracellular vescicles (exososmes-ectososmes); cancer metabolism
Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
Interests: tumor microenvironment; tumor immunology; radiotherapy; immunotherapy
Interests: tumor microenvironment; tumor immunology; radiotherapy; immunotherapy
Institute of Chemical Biology and Fundamental Medicine SB RAS, 8, Lavrentiev Ave., 630090 Novosibirsk, Russia
Interests: biomaterials; hybrid materials; dendrimers; dendrons; oligonucleotides; nucleic acid therapeutics; nanotechnology; bionanotechnology; drug delivery
Interests: biomaterials; hybrid materials; dendrimers; dendrons; oligonucleotides; nucleic acid therapeutics; nanotechnology; bionanotechnology; drug delivery
Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Roma, Italy
Interests: thyroid cancer; neuroendocrine tumors; multiple endocrine neoplasia; parathyroid diseases; pituitary diseases; adrenal tumors
Interests: thyroid cancer; neuroendocrine tumors; multiple endocrine neoplasia; parathyroid diseases; pituitary diseases; adrenal tumors
1. SKAGGS, School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA, USA
2. Department of Pharmacy Practice, Faculty of Pharmacy, University of Sindh, Jamshoro, Pakistan
Interests: cancers; virology; medicine; public health; adverse drug reactions
2. Department of Pharmacy Practice, Faculty of Pharmacy, University of Sindh, Jamshoro, Pakistan
Interests: cancers; virology; medicine; public health; adverse drug reactions
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Interests: prostate cancer; melanocytes; breast cancer; Protein Kinase; extracellular signal pathway; melanoma
Interests: prostate cancer; melanocytes; breast cancer; Protein Kinase; extracellular signal pathway; melanoma
